tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Zevra Therapeutics Inc

ZVRA
Add to Watchlist
9.510USD
-0.130-1.35%
Close 07-31 16:00（ET）Quotes delayed by 15 min
562.18MMarket Cap
4.51P/E TTM

Zevra Therapeutics Inc

9.510
-0.130-1.35%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ZVRA Financials

See Zevra Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Zevra Therapeutics Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/0.11
Revenue / Forecast
--/33.88M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
106.47M
350.91%
EPS(YoY)
1.40
161.49%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
1232.36%0.65
131.38%0.21
98.60%-0.01
386.77%1.36
85.60%-0.06
-30.09%-0.67
-132.78%-0.69
-526.55%-0.48
-3.75%-0.40
-408.33%-0.51
---0.30
---0.08
---0.38
--0.17
---0.94
----
----
----
----
----
Revenue
77.54%36.22M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.40M
-6.79%12.04M
27.63%3.69M
-47.47%4.45M
7.84%3.42M
538.97%12.92M
0.73%2.90M
551.54%8.47M
-19.90%3.18M
-21.69%2.02M
46.26%2.87M
-89.15%1.30M
-67.28%3.96M
9.13%2.58M
2.08%1.96M
73.51%11.99M
Net Profit
1322.65%37.89M
133.10%11.83M
98.36%-544.00K
474.94%74.71M
81.36%-3.10M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
312.73%5.75M
-276.12%-6.62M
-124.80%-24.04M
96.10%-1.86M
44.34%-2.70M
41.54%-1.76M
-1345.05%-10.70M
Net Margin
788.66%104.61%
112.01%35.65%
99.77%-2.09%
164.45%288.66%
96.87%-15.19%
-92.75%-296.76%
-151.10%-899.19%
-1374.28%-447.85%
-16.62%-485.31%
-154.14%-153.96%
---358.10%
---30.38%
---416.15%
--284.37%
---399.58%
----
----
----
----
----
Gross Margin
149.71%213.48%
25.76%94.62%
2371.13%94.04%
404.96%45.93%
70.04%85.49%
-10.99%75.24%
-104.36%-4.14%
-116.37%-15.06%
-47.66%50.28%
-14.54%84.53%
--95.03%
--92.01%
--96.06%
--98.91%
--97.54%
----
----
----
----
----
Debt to assets ratio
-100.00%0.00%
-34.89%21.75%
-26.19%22.70%
-41.37%23.68%
22.41%34.79%
34.61%33.41%
-2.59%30.75%
235.27%40.39%
134.51%28.42%
123.52%24.82%
--31.57%
--12.05%
--12.12%
--11.10%
--10.71%
----
----
----
----
----
Income Statement
Revenue
77.54%36.22M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.40M
-6.79%12.04M
27.63%3.69M
-47.47%4.45M
7.84%3.42M
538.97%12.92M
0.73%2.90M
551.54%8.47M
-19.90%3.18M
-21.69%2.02M
46.26%2.87M
-89.15%1.30M
-67.28%3.96M
9.13%2.58M
2.08%1.96M
73.51%11.99M
Operating profit
1072.51%52.15M
160.42%9.31M
115.17%4.14M
48.19%-12.33M
73.83%-5.36M
-1.71%-15.42M
-77.73%-27.31M
-280.60%-23.80M
-59.66%-20.49M
-62.75%-15.16M
-131.87%-15.36M
11.99%-6.25M
-590.21%-12.83M
-227.69%-9.31M
-198.20%-6.63M
-221.79%-7.10M
-126.71%-1.86M
11.63%-2.84M
-83.18%-2.22M
124.95%5.83M
Net Profit
1322.65%37.89M
133.10%11.83M
98.36%-544.00K
474.94%74.71M
81.36%-3.10M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
312.73%5.75M
-276.12%-6.62M
-124.80%-24.04M
96.10%-1.86M
44.34%-2.70M
41.54%-1.76M
-1345.05%-10.70M
Balance Sheet
Current assets
181.92%229.97M
159.23%223.01M
126.38%225.12M
271.71%226.34M
29.71%81.57M
-1.05%86.03M
-27.42%99.44M
-41.13%60.89M
-39.69%62.89M
-6.35%86.94M
60.94%137.01M
18.29%103.43M
-1.42%104.28M
-19.31%92.83M
-36.77%85.13M
-35.80%87.44M
20.58%105.78M
1272.66%115.06M
1553.12%134.63M
1402.27%136.18M
Total current liabilities
74.33%47.03M
15.30%39.28M
-24.27%26.11M
-5.31%28.83M
-9.81%26.98M
-53.79%34.06M
58.80%34.48M
66.83%30.45M
91.53%29.91M
513.16%73.72M
157.55%21.71M
154.95%18.25M
430.25%15.62M
184.23%12.02M
127.99%8.43M
20.14%7.16M
-30.51%2.94M
-43.87%4.23M
-94.78%3.70M
-91.79%5.96M
Total assets
61.30%278.58M
59.85%284.73M
41.02%270.12M
77.47%256.28M
14.16%172.71M
3.37%178.13M
37.82%191.55M
36.86%144.41M
41.92%151.28M
49.41%172.33M
16.25%138.98M
-15.08%105.52M
-15.20%106.59M
-13.24%115.34M
-12.85%119.55M
-10.48%124.26M
39.00%125.71M
1086.02%132.94M
1124.44%137.19M
1025.87%138.80M
Total liabilities
-44.74%72.78M
-6.06%130.07M
12.46%136.95M
24.23%139.05M
28.52%131.69M
25.35%138.46M
70.29%121.78M
202.36%111.93M
191.17%102.47M
174.65%110.46M
177.64%71.51M
47.93%37.02M
736.49%35.19M
590.71%40.22M
372.69%25.76M
207.66%25.02M
-31.97%4.21M
-92.50%5.82M
-92.59%5.45M
-89.18%8.13M
Total equity
401.68%205.80M
289.90%154.66M
90.86%133.16M
260.95%117.23M
-15.97%41.02M
-35.88%39.67M
3.41%69.77M
-52.59%32.48M
-31.63%48.82M
-17.65%61.86M
-28.07%67.47M
-30.97%68.50M
-41.23%71.40M
-40.91%75.12M
-28.80%93.79M
-24.05%99.23M
44.21%121.50M
291.41%127.12M
311.36%131.74M
307.85%130.66M
Cash Flow Statement
Net operating income
174.70%6.14M
133.94%5.52M
125.96%4.71M
81.16%-3.60M
49.14%-8.22M
-0.57%-16.25M
-291.98%-18.14M
-119.54%-19.11M
-299.63%-16.16M
-262.12%-16.16M
29.86%-4.63M
-108.63%-8.70M
-13.85%-4.04M
-426.18%-4.46M
-141.68%-6.60M
-125.13%-4.17M
-37.39%-3.55M
19.92%-848.00K
-159.75%-2.73M
657.09%16.60M
Net investment
655.25%79.62M
104.15%227.00K
85.41%-4.58M
9351.16%11.93M
-28.74%10.54M
-151.69%-5.47M
29.47%-31.35M
-100.38%-129.00K
184.27%14.79M
16901.59%10.59M
-16444.12%-44.46M
202.89%34.04M
-356.21%-17.55M
99.59%-63.00K
6900.00%272.00K
-40739.51%-33.08M
---3.85M
-59280.77%-15.44M
---4.00K
-2125.00%-81.00K
Net financing
-3385.87%-52.80M
219.85%2.55M
-89.92%6.53M
-90.99%1.38M
32.05%1.61M
-84.09%796.00K
146.64%64.77M
1511.99%15.33M
132.45%1.22M
2047.08%5.00M
6520.29%26.26M
-93.12%951.00K
20.77%-3.75M
91.05%-257.00K
-121.06%-409.00K
-65.23%13.82M
-106.37%-4.73M
-6139.13%-2.87M
3907.84%1.94M
2088.71%39.75M

FAQs

What is the total revenue of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its total revenue reached 106.47M, with a year-on-year change of 23.61M.

What are the current assets of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its current assets were 223.01M, with a year-on-year change of 159.23.

What are the total assets of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its total assets of Zevra Therapeutics Inc were 284.73M, with a year-on-year change of 59.85.

What are the total liabilities of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its total liabilities of Zevra Therapeutics Inc were 130.07M, with a year-on-year change of -6.06.

What is the total equity of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its total equity of Zevra Therapeutics Inc was 154.66M, with a year-on-year change of 289.90.

What is the net operating income of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its net operating income of Zevra Therapeutics Inc was -4.23M, with a year-on-year change of 95.13.

What is the net investment of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its net investment of Zevra Therapeutics Inc was 18.13M, with a year-on-year change of 181.80.

What is the net financing of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its net financing of Zevra Therapeutics Inc was 12.06M, with a year-on-year change of -85.31.

What is the Earnings Per Share (EPS) of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.40, with a year-on-year change of 161.49.

What is the net income of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its net income was 77.58M, with a year-on-year change of 173.53.

What is the net margin of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its net profit margin was 78.17, with a year-on-year change of 117.49.

What is the gross margin of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its gross margin was 80.89, with a year-on-year change of 91.77.

What is the debt-to-asset ratio of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 21.75, with a year-on-year change of -34.89.

What is the Return on Equity (ROE) of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 79.85, with a year-on-year change of 138.42.

What is the Return on Assets (ROA) of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 35.96, with a year-on-year change of 159.73.

What is the operating profit of Zevra Therapeutics Inc?

According to Zevra Therapeutics Inc's FY2025 earnings report, its operating profit was -4.23M, with a year-on-year change of 95.13.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy